Status:
COMPLETED
OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma
Lead Sponsor:
Oxagen Ltd
Conditions:
Mild to Moderate Persistent Asthma
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
This will be a double blind, randomised, 4 arm, parallel group, placebo controlled study of three dose levels of OC000459 tablets in patients with asthma controlled by beta agonist drugs alone. This s...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Male or female asthmatics, any racial group. Females of childbearing potential must practise two forms of contraception
- Aged 18 to 55 years inclusive.
- Non smokers for at least the past 12 months with a pack history of less than 10 pack years.
- Mild to moderate persistent asthma according to GINA4 guidelines for at least 12 months
- Exclusion criteria:
- Receipt of prescribed or over the counter medication within 14 days prior to the first study day
Exclusion
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2010
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT00890877
Start Date
April 1 2009
End Date
July 1 2010
Last Update
September 2 2010
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Research site
Sofia, Bulgaria
2
Research site
Győr, Hungary
3
Research site
Warsaw, Poland
4
Research site
Bucharest, Romania